Cargando…
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment
OBJECTIVES: The present study was designed to evaluate the bone phenotypes and mechanisms involved in bone disorders associated with hepatic osteodystrophy. Hepatocellular disease was induced by carbon tetrachloride (CCl(4)). In addition, the effects of disodium pamidronate on bone tissue were evalu...
Autores principales: | Spirlandeli, Adriano L., Dick-de-Paula, Ingrid, Zamarioli, Ariane, Jorgetti, Vanda, Ramalho, Leandra N.Z., Nogueira-Barbosa, Marcello H., Volpon, Jose B., Jordão, Alceu A., Cunha, Fernando Q., Fukada, Sandra Y., de Paula, Francisco J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401620/ https://www.ncbi.nlm.nih.gov/pubmed/28492723 http://dx.doi.org/10.6061/clinics/2017(04)07 |
Ejemplares similares
-
Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
por: Pereira, F.A., et al.
Publicado: (2012) -
Overview of renal osteodystrophy in Brazil: a cross-sectional
study
por: Carbonara, Cinthia E.M., et al.
Publicado: (2023) -
Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?
por: Da Silva Martins, Janaina, et al.
Publicado: (2017) -
Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO
por: Carbonara, Cinthia Esbrile Moraes, et al.
Publicado: (2020) -
Effects of Different Vegetable Oils on the Nonalcoholic Fatty Liver Disease in C57/BL Mice
por: Manca, Camila Sanches, et al.
Publicado: (2023)